FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

AmeriSource Bergen Ifosfamide Injection 3g/60 mL Recall

Ifosfamide Injection 3g/60 mL, Single dose vial, Rx only, Sterile, For Intravenous Use,…

AmeriSource Bergen · Chesterbrook, PA

Risk level
Class II
Reported by FDA
Oct 9, 2013
Recall ID
D-1066-2013
Check your lot numberHow we source this data

Summary

AmeriSource Bergen recalled Ifosfamide Injection 3g/60 mL starting Sep 13, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1066-2013 on Oct 9, 2013. Reason: Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers. Status: Terminated.

Why it was recalled

Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.

Product description

Ifosfamide Injection 3g/60 mL, Single dose vial, Rx only, Sterile, For Intravenous Use, Refrigerate at 2-8 degrees celcius, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-4496-22

Lot numbers, UPCs & expiration codes

Lot #s: 7800929, 7800931, Exp 02/15; 7800962, Exp 03/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1066-2013
Classification
Class II
Status
Terminated
Recall initiated
Sep 13, 2013
FDA report date
Oct 9, 2013
Quantity
60 vials
Recall type
Voluntary: Firm initiated
Recalling firm
AmeriSource Bergen

Original FDA data

Every field from FDA enforcement report D-1066-2013, exactly as published.

Show all FDA fields
City
Chesterbrook
State
PA
Status
Terminated
Country
United States
Event ID
66316
Address
1300 Morris Dr
Code information
Lot #s: 7800929, 7800931, Exp 02/15; 7800962, Exp 03/15
Postal code
19087-5559
Report date
Oct 9, 2013
Product type
Drugs
Recall number
D-1066-2013
Classification
Class II
Recalling firm
AmeriSource Bergen
Product quantity
60 vials
Termination date
Oct 1, 2014
Reason for recall
Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ifosfamide Injection 3g/60 mL, Single dose vial, Rx only, Sterile, For Intravenous Use, Refrigerate at 2-8 degrees celcius, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-4496-22
Distribution pattern
Nationwide
Recall initiation date
Sep 13, 2013
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Sep 27, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1066-2013, published Oct 9, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls